SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG
0
Add to list
GB COVID-19 Ag POCT
Cat. No. 4ECO101E
More details>
(3 items)
SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG About GBC Our Brands R&D Media Join us Contact us
English 繁體中文
IVD Solutions
Menu
GB SARS-CoV-2 Ab
Semi-quantitative ELISA for SARS-CoV-2 Spike/N antibodies (IgG/IgM) with 100% sensitivity & specificity. 10 µL sample, 105-minute assay.
USEFUL RESOURCES
Add to List
>  PRODUCT DESCRIPTION>  SPECIFICATION>  PERFORMANCE>  COMPARISON>  ORDERING INFORMATION
PRODUCT DESCRIPTION
This product is a semi-quantitative ELISA reagent designed for detection of IgG and IgM antibodies to SARS-CoV-2 Spike or N protein in human serum or plasma. It uses a direct sandwich ELISA format on a 96-well plate. The test requires only 10 µL of sample and has a 105-minute incubation time with a 450 nm readout. Clinical validation shows 100% sensitivity and 100% specificity. Non-Reactive results indicate no detectable anti-SARS-CoV-2 antibodies; Reactive results signify presence of antibodies, to be interpreted alongside vaccination or infection history.
SPECIFICATION
Number of wells96
PrincipleDirect Sandwich
Assay formatSemi-Quantitative
Total incubation time105 minutes
Sample typeSerum or Plasma
Sample volume10 μL
Reading wavelength450nm
Storage2-8°C
CertificationRUO
PERFORMANCE

5 serum samples collected from RT-PCR confirmed COVID-19 patients were tested. 139 normal healthy patients with samples collected before COVID-19 outbreak were tested. The results are as follows:

PERFORMANCETest PositiveTest Negative
Confirmed Positive50
Confirmed Negative0139
Inter-assay precision CV< 10%Inter-assay precision CV< 20%

The diagnostic sensitivity is 100%;The diagnostic specificity is 100%

COMPARISON
 Negative (n=89)Positive (n=5)
Company ACompany A
PosNegtotalPosNegtotal
GBCPos000415
Neg28789000
total28789415
SensitivityGBC100%
Company A80%
SpecificityGBC100%
Company A97.7%
ORDERING INFORMATION
Catalogue No.Product
4ECO001GB SARS-COV-2 Ab ELISA - 96T
4ECO002GB SARS-COV-2 Ab ELISA - 480T